- Category
- Micro (2021-22)
- Udyam number
- UDYAM-WB-08-0018496

Rexilo Pharma Private Limited
About Rexilo Pharma Private Limited
Data last updated:
Rexilo Pharma Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2021PTC250044.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sk Sanu and Sk Abul Basar.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401.
As per the financials filed for FY 2023, the company reported a revenue of ₹16.74 Lakh. For the same year it recorded a net loss of ₹13,178 (net margin -0.8%) and EBITDA of ₹68,077 (EBITDA margin 4.1%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Rexilo Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0018496).
Company details
Recognitions & Rankings of Rexilo Pharma
Contact details
Rexilo Pharma Private Limited's registered office is in Howrah, West Bengal.
- Registered AddressC/O Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rexilo Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rexilo Pharma Private Limited, buy the company report.
Financials of Rexilo Pharma Private Limited
FY 2023 filings availableRexilo Pharma Private Limited reported revenue of ₹16.74 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹68,077 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹13,178 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.1% | |
| Net Profit Margin | -0.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rexilo Pharma Private Limited, buy the company report.
Board of directors of Rexilo Pharma Private Limited
Rexilo Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sk Sanu | Director | 02 Dec 2021 | 4 Years 11 Months | Current |
| Sk Abul Basar | Director | 02 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Rexilo Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A B R Drugs Private Limited | ₹16.75 Lakh (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Febo Tradeguru Private Limited | ₹16.75 Lakh (FY 2023) | Kolkata, West Bengal, India | ||||
| Eastpoint Seeds Private Limited | ₹16.75 Lakh (FY 2023) | Bangalorerural, Karnataka, India | ||||
| Dev Bhoomi Recycling Private Limited | ₹16.75 Lakh (FY 2024) | -79.0% | Dehradun, Uttarakhand, India | |||
| Wemron Trading (OPC) Private Limited | ₹16.75 Lakh (FY 2022) | 0.0% | Patna, Bihar, India | |||
| Rexilo Pharma Private Limitedthis company | ₹16.74 Lakh (FY 2023) | -₹13,178 | -0.8% | Howrah, West Bengal, India | ||
| Excellent Exim & Commerce Pvt. Ltd. | ₹16.74 Lakh (FY 2024) | 10756.0% | Kolkata, West Bengal, India | |||
| Vedansh Hi-Tech Engineers Private Limited | ₹16.74 Lakh (FY 2022) | 345.0% | Nagpur, Maharashtra, India | |||
| Caegis Pharma (OPC) Private Limited | ₹16.74 Lakh (FY 2024) | -28.0% | New Delhi, Delhi, India | |||
| Pureorganics and Foods India Private Limited | ₹16.73 Lakh (FY 2025) | 43.0% | New Delhi, Delhi, India | |||
| Shulyn Realty Private Limited | ₹16.73 Lakh (FY 2024) | Gautam Budh Nagar, Uttar Pradesh, India |
To see the full peer comparison of Rexilo Pharma Private Limited, buy the company report.
Legal cases
Rexilo Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Court case (CN) | Filed against the company by P. Hematlal and Co. | Pending |
To see the full case history of Rexilo Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexilo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rexilo Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rexilo Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sk Abul Basar was appointed as Director on 02 Dec 2021.
Frequently asked questions
Rexilo Pharma is an active private limited company based in Howrah, West Bengal, India. The company works in specialty, within the trading industry. It was incorporated on 02 December 2021 (5+ years old) and is registered under CIN U51909WB2021PTC250044.
Rexilo Pharma has 2 current directors:
- Sk Sanu - Director
- Sk Abul Basar - Director
The latest financial statements of Rexilo Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Rexilo Pharma is U51909WB2021PTC250044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexilo Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Rexilo Pharma was incorporated on 02 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Rexilo Pharma by revenue are A B R Drugs Private Limited, Febo Tradeguru Private Limited, Eastpoint Seeds Private Limited, Dev Bhoomi Recycling Private Limited, Wemron Trading (OPC) Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sk Abul Basar was appointed as Director on 02 Dec 2021. Sk Sanu was appointed as Director on 02 Dec 2021.
Yes, Rexilo Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0018496).
The registered office of Rexilo Pharma is at CO Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401.
Rexilo Pharma operates in the trading industry, in the specialty segment.

